- Report
- May 2024
- 145 Pages
Global
From €3498EUR$3,950USD£3,059GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3055EUR$3,450USD£2,671GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4206EUR$4,750USD£3,678GBP
- Report
- May 2023
- 116 Pages
Global
From €3985EUR$4,500USD£3,484GBP
- Report
- July 2025
- 200 Pages
India
From €2470EUR$2,789USD£2,160GBP
- Report
- June 2025
- 250 Pages
Canada
From €2470EUR$2,789USD£2,160GBP
- Report
- August 2024
- 150 Pages
Global
From €2470EUR$2,789USD£2,160GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3426EUR$3,869USD£2,996GBP
- Report
- May 2023
- 160 Pages
Global
From €4382EUR$4,949USD£3,832GBP
- Report
- May 2023
- 147 Pages
Global
From €4382EUR$4,949USD£3,832GBP
- Report
- March 2023
- 147 Pages
Global
From €4382EUR$4,949USD£3,832GBP
- Report
- March 2023
- 147 Pages
Global
From €4382EUR$4,949USD£3,832GBP
- Report
- February 2024
- 125 Pages
Asia Pacific
From €3055EUR$3,450USD£2,671GBP
- Report
- October 2022
- 181 Pages
Africa, Middle East
From €3055EUR$3,450USD£2,671GBP
- Report
- October 2022
- 177 Pages
From €3055EUR$3,450USD£2,671GBP
- Report
- October 2022
- 174 Pages
North America
From €3055EUR$3,450USD£2,671GBP
- Report
- July 2023
- 160 Pages
Global
From €4382EUR$4,949USD£3,832GBP
- Report
- May 2023
- 160 Pages
Global
From €4382EUR$4,949USD£3,832GBP
- Report
- February 2024
- 141 Pages
Global
€4423EUR$4,995USD£3,868GBP
- Report
- November 2021
- 124 Pages
Global
From €13277EUR$14,995USD£11,611GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more